Clinical Trial Update: A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk [Phase 4]

View source ↗

Summary

Phase 4 trial comparing a multi-risk factor strategy to guideline-based approach for achieving blood pressure and lipid goals in high-risk hypertensive patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Dyslipidemia, Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2009-11-06